Nuclear hormone receptors (NRs) activate transcription by binding to specific enhancer elements associated with target genes. Transcriptional activation is accomplished with the help of complexes of co-activator proteins that bind to NRs. p160 co-activators, a family of three related 160 kDa proteins, serve as primary co-activators by binding directly to NRs and recruiting additional secondary co-activators. Some of these (CBP/p3OO and p/CAF) can acetylate histones and other proteins in the transcription complex, thus helping to modify chromatin structure and form an active transcription initiation complex. We recently discovered co-activator-associated arginine methyltransferase 1 (CARMl), which binds to pl60 co-activators and thereby enhances transcriptional activation by NRs on transiently transfected reporter genes. CARMl also methylates specific arginine residues in the N-terminal tail of histone H3 in vitro. A related argininespecific protein methyltransferase, P R M T l , also binds p160 co-activators and enhances N R function. P R M T l methylates histone H4 in vitro. T h e enhancement of N R function by CARMl , P R M T l and p300 depends on their interactions with p160 co-activators. In the presence of p160 co-activators, some pairs of these three secondary co-activators provide a highly synergistic enhancement of NR function on transiently transfected reporter genes. We have also observed an enhancement of N R function on stably integrated reporter genes by these co-activators. We propose that the synergy of co-activator function between p300, CARMl and P R M T l is due to their
Introduction
Nuclear hormone receptors (NRs) are a large family of transcriptional activators, many of which are hormonally regulated. Members include receptors for the steroid and thyroid hormones, retinoic acid and vitamin D as well as a large number of so-called orphan receptors for which an activating ligand is unnecessary or unknown [l-31. Transcriptional activation by NRs, as well as by other DNA-binding transcriptional activators, involves their ability to promote the local remodelling of chromatin structure and the recruitment of an RNA polymerase I1 transcription initiation complex to the promoter [4, 5] . NRs accomplish these tasks with the help of complexes of transcriptional co-activator proteins, which are recruited to the promoter by interaction with the activation domains of the NRs, namely AF-1 located at the N-terminus of the NRs and AF-2 located within the C-terminal hormone-binding domain [4, 6, 7] . Among many proteins discovered to interact with NRs and enhance NR activity in transient transfection assays are some with ATPdependent nucleosome remodelling activity, some with protein acetyltransferase or protein methyltransferase activities, others that can bind to and possibly help to recruit components of the transcription initiation complex, and many for which the mechanism of action is unknown [4, 6, 8, 9] .
This article focuses on a family of three 160 kDa proteins called the p160 co-activators and on other N R co-activators that associate with the pl60 co-activators. T h e p160 co-activators, which include SRC-I, GRIP1 (also called T I F 2 ) and pCIP (also called ACTR, AIB1, RAC3 and TRAMl), have in the central region of the polypeptide chain three or more NR box motifs with the sequence Leu-Xaa-Xaa-Leu-Leu, which bind directly to the AF-2 region of all NRs that function as transcriptional activators [4, 6] . In addition, the AF-1 regions of some but not all NRs bind to the C-terminal region of pl60 co-activators [7] . Having been recruited to the promoter by these interactions with NRs, the p160 coactivators transmit the activating signal to the promoter through at least two activation domains (ADS). AD1, located near residue 1000 of the 1400-residue polypeptide chain, is a binding site for members of another co-activator family, p300 and CREB-binding protein (CBP), which function as co-activators for many different types of DNA-binding transcriptional activator protein [10, 11] . CBP and p300 have several different potential mechanisms of co-activator function, including but probably not restricted to the acetylation of histones and other proteins in the transcription initiation complex, and binding to other components of the transcription initiation complex [10, . AD2, located in the C-terminal region of pl60 co-activators, has recently been shown to recruit co-activator-associated arginine methyltransferase 1 (CARMl), which contains a histone H3 methyltransferase activity [7, 16] . The co-activator activity of CARMl for NRs is completely dependent on the presence of p160 coactivators, which is consistent with a model that CARMl functions as a secondary co-activator; here a secondary co-activator is defined as one that is recruited to the promoter by NRs indirectly, i.e. not through a direct interaction with NRs but by binding to the primary p160 co-activator [16] .
The histone H3 methyltransferase activity of CARMl suggests that its co-activator function could be due to histone methylation; i.e. histone methylation might co-operate with histone acetylation, phosphorylation and other types of histone modification to modulate chromatin structure in a way that promotes transcriptional activation. Of course, methylation of other, as yet undefined, protein substrates by CARMl could also contribute to transcriptional activation, or CARM 1 could function as a co-activator by mechanisms unrelated to its methyltransferase activity.
In the current study we expanded our investigation of the protein methyltransferase class of NR co-activators by defining the amino acids of histone H3 that are methylated by CARMl and by testing another member of the CARMl protein family for NR co-activator activity. We also examined whether different co-activators that work by distinct mechanisms can function together in a synergistic manner to enhance NR function. Finally, we tested whether the p160 coactivators and their associated proteins can function as co-activators for stably integrated, as well as transiently transfected, reporter genes.
Results and discussion
Protein methyltransferase substrate specificity of CARM I T o characterize further the methyltransferase activity of CARM 1, we identified the specific amino acid residues of histone H3 that are methylated by CARMl in vitto. Histone H3 was methylated in vitro by recombinant CARMl in the presence of S-aden~syl[~'S]methionine. After acid hydrolysis and derivatization, HPLC and T L C were used with standards for various methylated amino acids to show that about two-thirds of the label was in p,p-dimethylarginine and the rest was in NOmonomethylarginine. Proteins related to CARMI by sequence homology, including protein arginine methyltransferase 1 (PRMTl), were previously shown to produce similar methylarginine products [17] . A combination of protease digestion, HPLC and MS were subsequently used to determine the specific Arg residues in histone H3 that were methylated by CARMl : major sites at Arg-17 and Arg-26, a minor site at Arg-2, and another site within a C-terminal tryptic peptide (residues 128-134) containing four Arg residues. The Nterminal sites are on the basic tail of the histone and are intermingled with sites of known acetylation and phosphorylation that are known to participate in nucleosome remodelling associated with transcriptional regulation [18] . These results are consistent with the hypothesis that the coactivator function of CARMl relies on its ability to methylate the N-terminal tail of histone H3 after recruitment to the promoter by NRs and p160 co-activators. Specific patterns of histone modification, including methylation, acetylation and phosphorylation, could collaborate to remodel chromatin structure and thereby facilitate transcriptional activation [ 181.
Co-activator function of another protein methyltransferase related to CARM I CARMl belongs to a family of related proteins that possess arginine-specific protein methyltransferase activities [ 16,193. Although they all methylate arginine residues of proteins, the specific protein substrates methylated by each methyltransferase in the family are different. One other member of this family, P R M T l , can methylate histone H4 as well as a number of RNAbinding proteins, none of which are substrates for CARM 1 [ 16, 191 . The homology between CARM 1 and P R M T l , and their shared ability to methylate histones (albeit different histones), led us to test whether PRMTl could also function as a co-activator for NRs. Indeed, like CARMl, P R M T l was able to bind to the C-terminal AD2 region of pl60 co-activators. Furthermore, in transiently transfected mammalian cells (CV-1 cells) P R M T l enhanced the ability of NRs to activate a transiently transfected reporter gene if a p160 coactivator was also transiently expressed.
Synergy between secondary NR co-activators CARM I, PRMT I and p300
The p160 co-activators can be thought of as primary co-activators for NRs because they act through their direct binding to NRs. In contrast, CARMl and P R M T l bind to and require the presence of p160 co-activators and thus might function as secondary co-activators. Because CBP and p300 bind to NRs and to p160 co-activators
[lo], we tested whether their co-activator function for NRs also requires the presence of p160 coactivators. In transient transfections we observed an enhancement of NR function by p300 only when a p160 co-activator was present. We next substituted mutants of G R I P l , lacking A D l , AD2 or both A D regions for wild-type G R I P l . Deletion of the AD1 region eliminated the coactivator effect of p300 but did not interfere with the co-activator function of CARMl and P R M T l . Conversely, deletion of the AD2 region eliminated the co-activator function of CARMl and P R M T l but did not interfere with the function of p300. Thus CARM1, P R M T l and p300 all seem to function as secondary co-activators ; i.e. their contact with p160 co-activators is essential for their co-activator function.
T h e potentially complementary abilities of CARMl and P R M T l to methylate different histones [16] led us to test whether CARMl and P R M T l have synergistic co-activator activities for NRs. Furthermore, the fact that the protein methyltransferases (CARMl and PRMT1) and the protein acetyltransferases (e.g. p300) act through different regions of the p160 coactivators, and might function by virtue of different types of protein (histone) modification activity, also led us to test for potential functional synergy between these co-activators. In transient transfection assays a combination of CARMl with either P R M T l or p300 produced a very strong synergistic enhancement of reporter gene activation by NRs. This was true for the hormonebinding NRs (including the oestrogen, androgen and thyroid hormone receptors) and orphan or hormone-independent NRs such as the oestrogenreceptor-related proteins or ERRS. However,
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there was little synergy when P R M T l was combined with p300. T h e action of the secondary coactivators, singly or in combination, was completely dependent on the presence of the NR and a p160 co-activator.
T h e degree of synergy observed varied markedly, depending on the level of NR expression vector used. At the relatively high levels of N R expression vector typically used in transient transfections (e.g. 0.1-0.5pg of a vector driven by a simian virus 40 promoter for a culture dish 3.3 cm in diameter), NRs were active in the absence of any exogenously supplied co-activator expression vectors; co-expression of a p160 co-activator enhanced reporter gene activity, and co-expression of a p160 co-activator plus any one of the secondary co-activators caused a further enhancement of activity. However, adding an additional secondary co-activator had little or no effect. As the amount of NR expression vector was decreased, the degree of synergy between two secondary co-activators increased. At very low levels of N R expression vector (1-long per 3.3-cm diameter dish), N R (in the presence of hormone, if required) produced no activity above the level observed with the reporter gene alone. T h e addition of a p160 co-activator along with NR also caused no increase in activity. NR plus p160 coactivator plus any one of the three secondary coactivators produced a small (2-6-fold) enhancement of activity. However, the addition of N R together with p160 and two secondary coactivators produced a marked synergistic enhancement of activity, which could be as high as 100-fold the level of activity observed when any one of the components (NR, p160 or either of the two secondary co-activators) was omitted.
T h e different co-activator requirements observed at high and low NR levels suggest that supraphysiological levels of NRs can accomplish chromatin remodelling and recruitment of a transcription initiation complex with less assistance from co-activators. For example, higher NR levels might result in a higher occupancy of NR-binding sites on the promoters of reporter genes. Because transient transfections generally result in protein expression levels that are higher than physiological, the concentrations achieved at the lower levels of expression vectors used here might be closer to physiological levels. At the lower N R levels the activity of the transiently transfected NR-dependent reporter gene was almost completely dependent on the co-expression of N R and three different co-activators, i.e. a p160 co-ac-tivator and two secondary co-activators (CARM 1 plus p300, or CARMl plus P R M T l ) . It will be interesting to test whether further adjustments in conditions might cause a dependence on more than three co-activators or other combinations of co-activators. In any case, these conditions provide a new experimental system under which to test the activities of the pi60 co-activators and their associated secondary co-activators.
Co-activator function with stably integrated reporter genes for NRs T h e transiently transfected reporter genes used in most co-activator studies so far do not have a chromatin structure typical of native, chromosomally integrated genes ; differences in the regulation of a reporter gene when it is transiently transfected as opposed to stably integrated have been reported [20] . We have therefore begun to develop a system for studying the activities of the NR co-activators on stably integrated reporter genes. A mammalian cell line with multiple copies of an integrated C A T (chloramphenicol acetyltransferase) reporter gene driven by an M M T V (murine-mammary-tumour virus) promoter was transiently transfected with vectors expressing NRs and co-activators, and transfected cells were separated from non-transfected cells in the culture to decrease the background reporter gene activity. We observed hormone-dependent activation by androgen and glucocorticoid receptors, which could be modestly enhanced by p160 co-activator GRIP1 and further enhanced by co-expression of CARMl and P R M T l . This system will permit the study of NR and co-activator function on a reporter gene with native chromatin structure and among other questions will allow us to test whether histone methylation is correlated with chromatin remodelling and gene activation. 
